Safely dispose of your Wegovy pen & needle As soon as you have injected your medication, you must safely dispose of your needle
Medications such as GLP-1 therapies (including tirzepatide and semaglutideZepbound, Mounjaro, Wegovy, and Ozempic) can be powerful tools, but they are only one part of a safe, effective, and sustainable metabolic care strategy
However, they will not automatically move into Category 1, where the agency has stated it would generally not take action against compounders
The most widely prescribed GLP-1 RAs for weight management include: Semaglutide sold as Ozempic (diabetes) and Wegovy (weight loss), administered by weekly subcutaneous injection Tirzepatide sold as Mounjaro (diabetes) and Zepbound (weight loss), a dual GIP/GLP-1 agonist administered by weekly injection Liraglutide sold as Saxenda (weight loss) and Victoza (diabetes), administered by daily injection GLP-1 RAs were originally developed as diabetes treatments but have become widely used for obesity and weight management following large clinical trials showing substantial weight loss outcomes
Retatrutide is available in two quantities to accommodate varying experimental requirements
